Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MIDSTATE GASTROENTEROLOGY SPECIALISTS PC

NPI: 1487677951 · MERIDEN, CT 06451 · Gastroenterology Physician · NPI assigned 07/25/2006

$6.61M
Total Medicaid Paid
99,571
Total Claims
88,153
Beneficiaries
34
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSACK, DAVID (PRESIDENT)
NPI Enumeration Date07/25/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,286 $333K
2019 12,875 $708K
2020 13,100 $973K
2021 15,191 $1.11M
2022 16,358 $1.15M
2023 18,269 $1.22M
2024 16,492 $1.12M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 30,884 25,865 $1.34M
88305 Level IV - Surgical pathology, gross and microscopic examination 7,496 7,084 $1.19M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10,860 9,388 $667K
88313 5,618 5,384 $553K
45380 Colonoscopy, flexible; with biopsy, single or multiple 5,644 5,166 $536K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 10,172 9,262 $499K
88312 5,563 5,345 $382K
99243 3,627 3,434 $296K
00813 2,901 2,772 $211K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3,360 2,889 $195K
46221 2,193 1,475 $184K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1,655 1,440 $135K
00731 2,239 2,132 $131K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1,017 923 $106K
99244 Office or other outpatient consultation, moderate to high complexity 465 428 $53K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 471 440 $42K
00811 442 424 $25K
96415 1,066 927 $19K
99215 Prolong outpt/office vis 307 254 $15K
00812 251 247 $14K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 87 79 $9K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 325 274 $3K
99253 43 39 $2K
J3380 Injection, vedolizumab, intravenous, 1 mg 360 327 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 68 60 $2K
99232 Subsequent hospital care, per day, moderate complexity 90 49 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 305 254 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 20 18 $1K
J7050 Infusion, normal saline solution, 250 cc 1,547 1,348 $753.68
J2919 Injection, methylprednisolone sodium succinate, 5 mg 90 81 $692.99
99233 Prolong inpt eval add15 m 18 13 $557.60
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 12 12 $539.76
99442 14 13 $521.12
J1200 Injection, diphenhydramine hcl, up to 50 mg 361 307 $128.25